Do Shock Patients Need an Arterial Line Right Away?
We break down the EVERDAC trial, a multicenter randomized study asking whether critically ill patients with shock really need an immediate arterial line. The episode covers noninferior mortality outcomes, major reductions in catheter-related bleeding, and how this could shift ICU practice toward a more selective, noninvasive approach.
Show Notes
- Deferring Arterial Catheterization in Critically Ill Patients with Shock | New England Journal of Medicine: https://www.nejm.org/doi/full/10.1056/NEJMoa2502136
Chapter 1
The ICU Arterial Line Reflex and the EVERDAC Trial
Dr. James Whitfield
You know, for decades in the ICU, the very second a patient drops their blood pressure into shock, there is this immediate, almost instinctive urge to put in an arterial line. It is like an automatic reflex.
Dr. Elena Rodriguez
Right, because you feel like you cannot safely manage a vasopressor drip without a continuous, beat to beat wave form on the monitor, right? But placing that arterial catheter is not totally benign.
Dr. James Whitfield
Exactly. You have risks of localized bleeding, hematoma formation, vascular damage, severe infection. And yet, putting the line in right away became an unquestioned unit norm in intensive care units everywhere. Which is why this new study in the New England Journal of Medicine, the EVERDAC trial by Doctor Muller and colleagues, is so striking.
Dr. Elena Rodriguez
The EVERDAC trial. They set out to ask if deferring that routine early arterial catheterization is actually noninferior to doing it immediately. Um, how exactly did they design the study to test that safely?
Dr. James Whitfield
It was a multicenter, open label, noninferiority randomized trial carried out across multiple ICUs in France. They enrolled 1,010 adult patients who had been admitted with shock within the preceding 24 hours. They randomized them into two distinct groups.
Dr. Elena Rodriguez
One thousand and ten patients, okay. And so the early group got the catheter put in within four hours, right? What was the alternative protocol for the deferred group?
Dr. James Whitfield
The deferred group, 504 patients, were managed with a noninvasive strategy using an automated brachial blood pressure cuff. The early group had 502 patients who got immediate arterial lines within four hours. The primary outcome they were tracking was 28 day all cause mortality, with a prespecified noninferiority margin of five percentage points.
Dr. Elena Rodriguez
Five percentage points. So if the noninvasive group did not perform worse by more than five percent on mortality, the deferred approach would meet its noninferiority endpoint.
Dr. James Whitfield
Precisely. And as someone who spent years on call in the ICU, I, I, I mean, the muscle memory is real. When the mean arterial pressure drops below 65, your hand wants that radial line immediately. So questioning whether that initial procedure is even necessary for everyone is a huge conceptual shift.
Chapter 2
Mortality Outcomes Bleeding Risk and Clinical Practice
Dr. Elena Rodriguez
So what did the mortality numbers actually look like at 28 days? Did the noninvasive strategy hold up?
Dr. James Whitfield
It did. At day 28, mortality was 34.3 percent in the deferred noninvasive group, that is 173 out of 504 patients. In the early invasive group, mortality was 36.9 percent, or 185 out of 502 patients. That gave an adjusted risk difference of minus 3.2 percentage points, with a 95 percent confidence interval from minus 8.9 to 2.5 percentage points. The P value for noninferiority was 0.006.
Dr. Elena Rodriguez
Minus 3.2 percentage points. So management without early arterial catheter insertion was noninferior to early catheter insertion. That is remarkable. But, wait, how many of those patients in the deferred group ended up needing an arterial line later anyway?
Dr. James Whitfield
That is the key crossover metric. 85.3 percent of the patients in the noninvasive group never required an arterial catheter at all. Only 14.7 percent, or 74 out of 504 patients, crossed over because they met specific safety criteria like severe hemodynamic instability or needing frequent arterial blood gas samples.
Dr. Elena Rodriguez
Over 85 percent avoided an invasive line completely. And if you avoid putting in a catheter, you ought to avoid catheter complications too, right? What did the safety data show on bleeding?
Dr. James Whitfield
The safety benefit was very clear. Catheter related hematoma or hemorrhage dropped from 8.2 percent, that is 41 out of 502 patients in the early catheter group, down to just 1.0 percent, or five out of 504 patients in the deferred group. Now, the trade off was slightly more patient reported discomfort from frequent cuff inflations, 13.1 percent versus 9.0 percent.
Dr. Elena Rodriguez
A tight blood pressure cuff squeezing your arm every few minutes is definitely annoying, but compared to an 8.2 percent chance of a catheter hematoma or bleeding, I think most patients and clinicians would take the cuff discomfort every single time.
Dr. James Whitfield
Absolutely. But let us be clear about how to apply this at the bedside. This trial does not mean we never place arterial lines in shock. If a patient is in profound vascular collapse, or rapidly escalating high dose vasopressors, or needs continuous arterial blood gases every 30 minutes, you still put the line in.
Dr. Elena Rodriguez
Right, it changes the default setting from an immediate procedural reflex to a deliberate, wait and see noninvasive monitor approach for stable shock presentation. You protect the majority from an unnecessary procedure while keeping the line ready for the 15 percent who actually need it.
Dr. James Whitfield
Well said. Good chatting with you on this one, Elena.
Dr. Elena Rodriguez
Same here, James. Catch you next time.